<DOC>
	<DOCNO>NCT00813137</DOCNO>
	<brief_summary>FOLFOX4 plus Avastin suggest firstline regimen advance colorectal cancer NCCN , new angiogenesis inhibitor , know Endostar ( Recombinant Human Endostatin ) , prolong overall survival , time progression improve response rate metastatic lung cancer large phase III clinical trial china , design trial evaluate safty efficacy FolFox4 plus Endostar patient advance colorectal cancer</brief_summary>
	<brief_title>FOLFOX4 Combined With Endostar Patients With Advanced Colorectal Cancer</brief_title>
	<detailed_description>Endostar free support Shangdong Simcere Medgene biotech co. , Ltd . Endostar combination Chemotherapy first line treatment regimen advance NSCLC . Clinical data prove Endostar wild spectrum safe antiangiogenesis factor could suppress almost 65 kind tumor mass animal model affect 12 percent human genome . China NCCN colon rectal cancer clinical practice guideline recommend Chemotherapy plus angiogenesis inhibitor first line treatment scheme . So design FOLFOX4 plus Endostar treat advance colorectal cancer research RR safety . We believe treatment regimen may new approach advance colorectal cancer patient .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Endostatins</mesh_term>
	<criteria>Patients histologically cytologically confirm metastatic CRC Measurable disease accord Response Criteria In Solid Tumours ( RECIST ) Performance Status 0 2 accord ECOG ( Eastern Cooperative Oncology Group ) Performance Status Age 18~75 Life expectancy &gt; 3 month Signed informed consent ( IC ) Adequate haematological biological function Pregnant lactate woman Known immediate delay hypersensitivity reaction idiosyncrasy drug chemically relate study drug Neuropathy , brain , leptomeningeal involvement Treatment biologic , cytotoxic , radiation , hormonal therapy within four week . Clinically relevant coronary artery disease history myocardial infarction within last 12 month high risk/uncontrolled arrhythmia Uncontrolled significant comorbid condition previous radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Colorectal Cancer</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>recombinant human endostatin</keyword>
</DOC>